Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ORGO
ORGANOGENESIS HOLDINGS INC.
NASDAQ
$1.71
▲ UP 4.27% (0.07)

KEY STATISTICS

Market Cap$220.03 M
52w High$7.08
52w Low$1.54
Dividend Yield—
Frequency—
P/E57.00
Volume665.51K
Shares Out.128.67M

COMPANY

LEADERSHIP

Gary S. Gillheeney
CHIEF EXECUTIVE
Gary S. Gillheeney

COMPENSATION 2026

Salary$979,105
Stock Awards$2,833,330
Incentive Plan Pay$1,536,575
All Other Comp.$82,727
Total$6,811,754

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 5, 2017
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
854

PRICE TARGET

Target High$3.00
Target Low$2.00
Target Median$2.50
Target Consensus$2.50

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$52.09M
NOV
5
THU

PRICE

$1.71 ▲ UP 4.27% (+$0.07)
$1.65$1.68$1.719:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM1.71

About Organogenesis Holdings Inc.

https://organogenesis.com ↗

Organogenesis Holdings Inc. develops and commercializes regenerative medicine solutions for wound care, surgical, and sports medicine markets in the U.S., including bioengineered tissues, membranes, and advanced healing products.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT ORGANOGENESIS HOLDINGS INC. IS KNOWN FOR

ReNu
ReNu

ReNu is a cryopreserved amniotic allograft for knee osteoarthritis, FDA BLA pending, with positive phase 3 results, representing Organogenesis's key product and growth focus in surgical and sports medicine.

COMPETITORS

COMPETITOR
IART COMPARE
MDXG COMPARE
SNN COMPARE
SYK COMPARE
VCEL COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product$150.49M $311.76M ▲$36.25M ▼$42.8M ▲
Grant$377K $536K ▲$978K ▲$950K ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
81
LISTED HERE
16
RANKED BY POSITION SIZE
VTS.AX
0.00% · 2.0M
IWM
0.00% · 1.8M
XSXD.SG
0.03% · 1.6M
SCHA
0.00% · 347.5K
DFSV
0.01% · 267.9K
FESM
0.00% · 165.0K
PRFZ
0.01% · 132.4K
R2US.L
0.00% · 119.1K
GSSC
0.02% · 117.9K
EES
0.02% · 101.8K
AVSC
0.01% · 101.3K
RSSL
0.00% · 32.8K
FLQS
0.02% · 4.9K
IVSS
0.03% · 4.7K
URTY
0.00% · 2.7K
DM
DMRS
0.06% · 1.5K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
49.23%
HOLDERS
181
TOP 12 OF 181 · RANKED BY POSITION SIZE
Soleus Capital Management, L.P.
12.1M sh · $51.2M
Morgan Stanley
11.8M sh · $49.78M
First Light Asset Management, LLC
7.5M sh · $31.64M
Blackrock Inc.
5.1M sh · $14.24M
Vanguard Group Inc
5.0M sh · $21.25M
Blackrock, Inc.
4.9M sh · $11.61M
Assenagon Asset Management S.A.
4.9M sh · $20.49M
Deutsche Bank AG\
3.3M sh · $17.08M
Dimensional Fund Advisors LP
2.9M sh · $12.28M
D. E. Shaw & Co., Inc.
2.3M sh · $5.45M
Geode Capital Management, LLC
1.8M sh · $9.26M
Acadian Asset Management LLC
1.8M sh · $7.39M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book4
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF COMMERCIAL OFFICER
Grow Brian
Purchase · 958 shares
2025-01-10
★
OFFICER: CHIEF COMMERCIAL OFFICER
Grow Brian
Sale · 958 shares
2025-01-10
★
DIRECTOR
Leibowitz Arthur S
Purchase · 5.0K shares
2026-03-09
★
DIRECTOR
Driscoll Michael Joseph
Purchase · 10.0K shares
2026-03-09

MOST RECENT ANALYST GRADES

GRADE SUMMARY
HOLD 1
BUY 1
2 GRADES IN THE LAST 12 MONTHS
Truist Securities HOLD BTIG BUY

SECTORS PEERS

PEERPRICE
MNPR$118.51COMPARE
VREX$18.51COMPARE
ANGO$14.98COMPARE
EOLS$9.20COMPARE
CMPX$2.39COMPARE
SNDL$1.43COMPARE
EBS$6.25COMPARE
BCYC$4.28COMPARE